Summary
Twenty patients with stable chronic bronchitis entered a double-blind study in which changes in clinical and respiratory function and biochemical and rheological variations were examined after treatment with the mucoregulator S-carboxy-methyl-cysteine (S.C.M.C.). After one week of single-blind placebo, a two week double-blind study was initiated with placebo or oral S.C.M.C. 3 g/24h. After two weeks, a significant clinical improvement was observed in patients treated with S.C.M.C. During treatment, there was no change in respiratory function, although a drop in FEV1/VC was noted in the placebo group. A significant increase in the viscosity of the expectorations was observed after treatment with S.C.M.C. for two weeks. The levels of secretory IgA and of serum albumin in the expectorations remained stable, whereas in the placebo group, there was a slight but significant increase in serum albumin. In this group of non-infected chronic bronchitic patients, S.C.M.C. appeared to normalize the secretory function of the bronchial mucosa by preventing inflammation and enhancing the viscoclastic properties of bronchial secretions.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anderson, G.: A clinical trial of a mucolytic agent=Acetylcysteine in chronic bronchitis. Br. J. Dis. Chest60, 101–108 (1966)
Autran, P., Boutin, C., Kleisbauer, J. P.: Utilisation clinique de la S.C.M.C. (sirop à 5%) et son effet sur la fluidification des sécrétions bronchiques. Lyon Méditer. med.51, 77–86 (1970)
Aylward, M.: An assessment of S.C.M.C. in the treatment of chronic bronchitis. Curr. Med. Res. Opin.2, 387–394 (1974)
Benis, A. M., Puchelle, E., Sadoul, P.: Adaptation of a concentric-cylinder rheometer to the routine measurement of the viscoelastic properties of sputum. In: Rheology of Biological systems. H. L. Gabelnick et M. Litt (eds.) Chapter 9, p. 219–259. Springfield, Illinois: C.C. Thomas 1972
Bürgi, H., Wiesmann, V., Richterich, R., Regli, J., Medici, T.: New objective criteria for inflammation in bronchial secretions. Bri. med. J.1968/II, 654–656
Clarke, S. W., Craig, G. M., Makin, E. J. B.: Clinical trial of brombexine in severe chronic bronchities during winter. Thorax27, 429–432 (1972)
Clarke, S. W.: The role of two-phase flow in bronchial clearance. Bull. Physiopath. Respir.9, 359–371 (1973)
Dulfano, M. J., Chen, J. M.: Mucus rheology and mucociliary clearance. Am. Rev. Respir. Dis.113, 200 (Abstract) (1976)
Edwards, G. F.: Clinical and rheological study of the effect of S-Carboxy-methylcysteine. Bull. Physiopath. Respir.9, 464–469 (1973)
Edwards, G. F., Steel, A. E., Scott, J. K., Jordan, J. W.: S-Carboxy-methyl-cysteine in the fluidification of sputum and treatment of chronic airway obstruction. Chest70, 506–513 (1976)
Fletcher, C. M.: Terminology, definitions and classifications of chronic emphysema and related conditions. Thorax14, 286–288 (1959)
Havez, R., Degand, P., Roussel, P., Randoux, A.: Mode d'action biochimique des dérivés de la cystéine sur la muqueuse bronchique. Poumon Coeur26, 81–90 (1970)
Havez, R., Roussel, P., Degand, P., Lamblin, G.: Elements de structure et activités biologiques des mucines bronchiques. In: Exposés annuels de biochimie médicale, Colloque sur les glycoprotéines 32è série. Paris: Masson 1973
Hayem, A., Laine, A., Bailleul, V., Lebas, J.: Determination quantitative des IgA du mucus bronchique humain. Clin. Chim. Acta61, 9–17 (1975)
Hirsch, S. R.: In vitro evaluation of expectorant and mucolytic agents. Bull. Physiopath. Resp.9, 435–438 (1973)
Hurst, G. A., Shaw, P. B., Le Maistre, C. A.: Laboratory and clinical evaluation of the mucolytic properties of acetylcysteine. Amer. Rev. Respir. Dis.95, 962–970 (1967)
Huyen, V. N.: Etude histochimique chez l'animal de l'activité de la S-Carboxy-méthyl-cystéine. Bull. Physiopath. Resp.9, 463–464 (1973)
Keal, E.: Modifications des propriétés physico-chimiques de l'expectoration dans divers états pathologiques et leur traitement. Poumon Coeur26, 25–34 (1970)
Lemercier, J.P., Langlois, A., Michel, M.J., Laumonier, R., Metayer, J.: Essai clinique d'un nouveau mucolytique, la S-Carboxy-méthyl-cystéine. Quest Méd.4, 411–416 (1970)
Macquet, V., Rogeaux, Y., Lafitte, P.: Emploi d'une association de S.C.M.C. et de théophylline dans le traitement de la bronchite chronique. Lille méd.18, 1023–1024 (1973)
Magliulo, E., Bonizzoni, D., Cattaneo, E., Scevola, D., Concia, E.: Studies of the clinical effectiveness of the mucolytic drug S.C.M.C. in the therapy of acute and chronic bronchitis. Minerva Med.66, 1187–1197 (1975)
Medical Research Council: Definition and classification of chronic bronchitis for clinical and epidemiological purposes. Lancet1965/1, 775–779
Molina, Cl., Aiache, J. M., Pradelle, J., Brun, J., Cheminat, J. C.: Intérêt clinique des médications fluidifiantes des sécrétions bronchiques. Poumon Coeur26, 91–102 (1970)
Muh, J. P., Latreille, J. P., Guerrin, F.: Recherche d'inhibiteurs naturels du bronchospasme à la bradykinine chez le cobaye. In: Hypersécrétion bronchique, colloque international de pathologie thoracique, p. 193–202. Clichy: Poissot 1968
Muittari, A., Linnoila, M.: Effects of mucolytics on chronic obstructive pulmonary disease. Curr. Ther. Res.22, 246–252 (1977)
Munies, R., Grubb, T. C., Caliari, R. E.: Relationship between sputum viscosity and total sialic acid content. J. Pharm. Sci.57, 824–827 (1968)
Pham, Q. T., Puchelle, E.: Les traitements par fluidifiants et par antibiotiques au cours des épisodes de surinfection des bronchiteux chroniques. Poumon Coeur26, 103–107 (1970)
Puchelle, E., Zahm, J. M., Havez, R.: Données biochimiques et rhéologiques dans l'expectoration. III Relation des protéines et mucines bronchiques avec les propriétés rhéologiques. Bull. Physiopath. Respir.9, 237–256 (1973)
Puchelle, E., Girard, F., Zahm, J. M.: Rhéologie des sécrétions bronchiques et transport muco-ciliaire. Bull. Europ. Physiopath. Resp.12, 771–779 (1976)
Quevauviller, A., Huyen, V. N., Garcet, S.: Méthodes d'étude expérimentale des modificateurs des sécrétions bronchiques. Poumon Cocur26, 71–79 (1970)
Sadoul, P., Puchelle, E., Girard, F.: Criteria for evaluating mucus function and their disorders in chronic bronchitis. In: Respiratory Tract Mucus. Ciba Foundation Symposium54, 277–291 (1978)
Sheffner, L. A.: The mucolytic activity, mechanism of action and metabolism of acetylcysteine. Pharmacology1, 47 (1965)
Thomson, M. L., Pavia, D., Jones, C. J., McQuiston, T. A. C.: No demonstrable effect of S-Carboxymethylcysteine on clearance of secretions from the human lung. Thorax30, 669–673 (1975)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Puchelle, E., Aug, F. & Polu, J.M. Effect of the mucoregulator S-carboxy-methyl-cysteine in patients with chronic bronchitis. Eur J Clin Pharmacol 14, 177–184 (1978). https://doi.org/10.1007/BF02089957
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02089957